Actuate Therapeutics (ACTU) vs Radiopharm Theranostics (RADX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Radiopharm Theranostics (RADX) has outperformed Actuate Therapeutics (ACTU) over the past year, losing 83.7% versus a loss of 89.7%. Radiopharm Theranostics is the larger company by market cap ($16.3 million vs $16.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACTU | RADX |
|---|---|---|
| Share price | $0.6701 | $1.12 |
| Market cap | $16.09M | $16.34M |
| 1-day change | -7.47% | -2.61% |
| YTD return | -88.17% | -77.97% |
| 1-year return | -89.71% | -83.66% |
| EPS (TTM) | $-0.87 | $-3.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.49 | $16.25 |
| 52-week low | $0.604 | $1.00 |
| Distance from 52-week high | -92.11% | -93.11% |
| Average volume | 391.80K | 84.62K |
| Shares outstanding | 24.01M | 14.59M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ACTU vs RADX FAQ
Which is bigger, Actuate Therapeutics or Radiopharm Theranostics?
Radiopharm Theranostics (RADX) is larger, with a market capitalization of $16.34M compared with $16.09M for Actuate Therapeutics (ACTU).
Which stock has performed better over the past year, ACTU or RADX?
RADX returned -83.66% over the past 12 months, compared with -89.71% for ACTU (price return, excluding dividends). Past performance does not predict future results.
Are Actuate Therapeutics and Radiopharm Theranostics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.